Skip to main content

and
  1. Article

    Open Access

    The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice

    Untreated neovascular age-related macular degeneration (nAMD) can lead to severe and permanent visual impairment. The chronic nature of the disease can have a significant impact on patients’ quality of life an...

    Ian Pearce, Winfried Amoaku, Clare Bailey, Louise Downey, Richard Gale in Eye (2022)

  2. Article

    Medical retina hotline: Service evaluation and assessment of efficacy of a novel system in a tertiary care hospital

    Aditi Ashok Kumar Agarwal, Ricardo Alberto Romero Fontenlos, Deepthy Menon in Eye (2022)

  3. Article

    Outcomes following implementation of a high-volume medical retina virtual clinic utilising a diagnostic hub during COVID-19

    To describe the clinical outcomes following implementation of a high-volume medical retina virtual clinic utilising a diagnostic hub.

    Daren Hanumunthadu, Khadra Adan, Kerry Tinkler, Konstantinos Balaskas in Eye (2022)

  4. No Access

    Article

    Prefilled Eylea Syringe: our recent experience

    Eleni Karatsai, Shruti Chandra, Sandro Fasolo, Sobha Sivaprasad, Robin Hamilton in Eye (2021)

  5. Article

    Open Access

    A virtual-clinic pathway for patients referred from a national diabetes eye screening programme reduces service demands whilst maintaining quality of care

    To evaluate the potential of an integrated virtual medical retina clinic in secondary care for diabetic patients screened and referred by the UK National Diabetic Eye Screening Program (DESP).

    Livia Faes, Dun Jack Fu, Josef Huemer, Christoph Kern, Siegfried K. Wagner in Eye (2021)

  6. No Access

    Article

    An open-source data set of anti-VEGF therapy in diabetic macular oedema patients over 4 years and their visual acuity outcomes

    The objective of this paper is to evaluate visual acuity (VA) outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) in diabetic macular oedema (DMO).

    Christoph Kern, Dun Jack Fu, Josef Huemer, Livia Faes, Siegfried K. Wagner in Eye (2021)

  7. No Access

    Article

    Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration

    Single center, noninterventional cohort study to assess 10-year visual and anatomical outcomes following initiation of treatment with antivascular endothelial growth factor (anti-VEGF) agents in neovascular ag...

    Shruti Chandra, Cristina Arpa, Deepthy Menon, Hagar Khalid, Robin Hamilton in Eye (2020)

  8. Article

    Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

    .

    Winfried M. Amoaku, Faruque Ghanchi, Clare Bailey, Sanjiv Banerjee, Somnath Banerjee in Eye (2020)

  9. Article

    The impact of COVID policies on acute ophthalmology services—experiences from Moorfields Eye Hospital NHS Foundation Trust

    Louisa Wickham, Gordon Hay, Robin Hamilton, Jack Wooding, Harry Tossounis in Eye (2020)

  10. Article

    Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group

    The management of diabetic retinopathy (DR) has evolved considerably over the past decade, with the availability of new technologies (diagnostic and therapeutic). As such, the existing Royal College of Ophthal...

    Winfried M. Amoaku, Faruque Ghanchi, Clare Bailey, Sanjiv Banerjee, Somnath Banerjee in Eye (2020)